Chemours (CC) Accumulated Expenses (2014 - 2026)

Chemours has reported Accumulated Expenses for 13 years, with the latest figure at $37.0 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses fell 90.66% year-over-year to $37.0 million; the trailing twelve-month figure through Mar 2026 stood at $37.0 million (down 90.66% YoY), and the FY2025 full-year result was $506.0 million, up 2711.11% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $37.0 million, down from $506.0 million in the prior quarter.
• The five-year high for Accumulated Expenses was $1.1 billion in Q4 2023, with the low at $17.0 million in Q4 2022.
• Average Accumulated Expenses over 5 years is $311.5 million, with a median of $111.0 million recorded in 2022.
• Year-over-year, Accumulated Expenses surged 6129.41% in 2023 and tumbled 98.3% in 2024.
• Tracing CC's Accumulated Expenses over 5 years: stood at $17.0 million in 2022, then surged by 6129.41% to $1.1 billion in 2023, then plunged by 98.3% to $18.0 million in 2024, then jumped by 2711.11% to $506.0 million in 2025, then slumped by 92.69% to $37.0 million in 2026.
• The last three Accumulated Expenses figures came in at $37.0 million (Q1 2026), $506.0 million (Q4 2025), and $580.0 million (Q3 2025), per Business Quant data.

Peer Comparison